Literature DB >> 12933785

Primary open angle glaucoma. The need for a consensus case definition.

M Kroese1, H Burton.   

Abstract

Primary open angle glaucoma is an important cause of visual impairment and blindness in the United Kingdom. This paper gives a brief overview of the condition and its management. It presents evidence of the continued absence of a consensus case definition for this condition. This has resulted in considerable uncertainty about what is diagnosed and treated as primary open angle glaucoma. The important negative effects of this situation are outlined. These include the impact on the person wrongly diagnosed with the condition, the uncertainties both for commissioning and provision of clinical healthcare services, and the lack of a firm basis for research into the condition. It is argued that there is an urgent need to resolve this problem to improve the health of the population.

Entities:  

Mesh:

Year:  2003        PMID: 12933785      PMCID: PMC1732569          DOI: 10.1136/jech.57.9.752

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  28 in total

1.  Utility of predictive equations for estimating the prevalence and incidence of primary open angle glaucoma in the UK.

Authors:  D C Minassian; A Reidy; M Coffey; A Minassian
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

Review 2.  New definitions of glaucoma.

Authors:  N Gupta; R N Weinreb
Journal:  Curr Opin Ophthalmol       Date:  1997-04       Impact factor: 3.761

3.  The age distribution of primary open angle glaucoma.

Authors:  M W Tuck; R P Crick
Journal:  Ophthalmic Epidemiol       Date:  1998-12       Impact factor: 1.648

4.  Epidemiology and screening of open-angle glaucoma.

Authors:  R P Crick
Journal:  Curr Opin Ophthalmol       Date:  1994-04       Impact factor: 3.761

5.  Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; K Attebo; P R Healey
Journal:  Ophthalmology       Date:  1996-10       Impact factor: 12.079

Review 6.  The role of medical therapy in the rank order of glaucoma treatment.

Authors:  J T Wilensky
Journal:  Curr Opin Ophthalmol       Date:  1999-04       Impact factor: 3.761

7.  The prevalence of glaucoma in the Melbourne Visual Impairment Project.

Authors:  M D Wensor; C A McCarty; Y L Stanislavsky; P M Livingston; H R Taylor
Journal:  Ophthalmology       Date:  1998-04       Impact factor: 12.079

8.  The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study.

Authors:  I Dielemans; J R Vingerling; R C Wolfs; A Hofman; D E Grobbee; P T de Jong
Journal:  Ophthalmology       Date:  1994-11       Impact factor: 12.079

9.  Changing definition of glaucoma.

Authors:  R Bathija; N Gupta; L Zangwill; R N Weinreb
Journal:  J Glaucoma       Date:  1998-06       Impact factor: 2.503

10.  The probability of blindness from open-angle glaucoma.

Authors:  M G Hattenhauer; D H Johnson; H H Ing; D C Herman; D O Hodge; B P Yawn; L C Butterfield; D T Gray
Journal:  Ophthalmology       Date:  1998-11       Impact factor: 12.079

View more
  6 in total

1.  The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003.

Authors:  C G Owen; I M Carey; S De Wilde; P H Whincup; R Wormald; D G Cook
Journal:  Br J Ophthalmol       Date:  2006-07       Impact factor: 4.638

Review 2.  Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension.

Authors:  Sheridan Henness; Tracy Swainston Harrison; Gillian M Keating
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

3.  Global rates of glaucoma surgery.

Authors:  Kaweh Mansouri; Felipe A Medeiros; Robert N Weinreb
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-09-26       Impact factor: 3.117

4.  The management of glaucoma and intraocular hypertension: current approaches and recent advances.

Authors:  Robert J Noecker
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

5.  Adapted motivational interviewing to improve the uptake of treatment for glaucoma in Nigeria: study protocol for a randomized controlled trial.

Authors:  Mohammed M Abdull; Clare Gilbert; Jim McCambridge; Jennifer Evans
Journal:  Trials       Date:  2014-04-29       Impact factor: 2.279

6.  Pro-fibrotic pathway activation in trabecular meshwork and lamina cribrosa is the main driving force of glaucoma.

Authors:  Alex Zhavoronkov; Evgeny Izumchenko; Riya R Kanherkar; Mahder Teka; Charles Cantor; Kebreten Manaye; David Sidransky; Michael D West; Eugene Makarev; Antonei Benjamin Csoka
Journal:  Cell Cycle       Date:  2016-06-17       Impact factor: 4.534

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.